Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Endogenous erythropoietin varies significantly with inflammation-related proteins in extremely premature newborns

  • J. Wells Logan
  • , Elizabeth N. Allred
  • , Raina N. Fichorova
  • , Stephen C. Engelke
  • , Olaf Dammann
  • , Alan Leviton
  • , Kathleen Lee
  • , Anne McGovern
  • , Jill Gambardella
  • , Susan Ursprung
  • , Ruth Blomquist
  • , Bhavesh Shah
  • , Karen Christianson
  • , Camilia R. Martin
  • , Linda J. Van Marter
  • , Robert M. Insoft
  • , Jennifer G. Wilson
  • , Maureen Pimental
  • , Cynthia Cole
  • , John M. Fiascone
  • Janet Madden, Ellen Nylen, Anne Furey, Francis Bednarek, Mary Naples, Beth Powers, Richard Ehrenkranz, Joanne Williams, Elaine Romano, T. Michael O'Shea, Debbie Gordon, Teresa Harold, Stephen C. Engelke, Sherry Moseley, Donna Pare, Carl Bose, Gennie Bose, Mariel Poortenga, Dinah Sutton, Carolyn Solomon, Nigel Paneth, Padmani Karna, Madeleine Lenski, Michael D. Schreiber, Grace Yoon, Daniel Batton, Beth Kring, Ken Wood, Deborah Hirtz
  • Ohio State University
  • Harvard University
  • Boston Children's Hospital
  • Department of Obstetrics, Gynecology and Reproductive Biology
  • Brigham and Women's Hospital
  • East Carolina University
  • Tufts University
  • Hannover Medical School
  • Baystate Medical Center
  • Beth Israel Deaconess Medical Center
  • Massachusetts General Hospital
  • Tufts Medical Center
  • University of Massachusetts Medical School
  • Yale University
  • Wake Forest University
  • University Health Systems of Eastern Carolina
  • University of North Carolina Children's Hospital
  • Spectrum Health
  • Sparrow Health System
  • Michigan State University
  • The University of Chicago
  • William Beaumont Hospital
  • Frontier Science & Technology Research Foundation
  • National Institutes of Health

Producción científica › revisión exhaustiva

20 Citas (Scopus)

Resumen

Introduction: Erythropoietin, a pluripotent glycoprotein essential for erythropoiesis, fetal growth, and development, has recently been implicated in innate immune regulation. Data from the ELGAN Study allowed us to evaluate relationships between endogenous erythropoietin and 25 inflammation-related proteins in extremely premature newborns. Methods: We measured the concentrations of 25 inflammation-related proteins and of erythropoietin in blood spots collected on postnatal days 1, 7, and 14 from 936 infants born before 28. weeks gestation. We calculated the odds that infants with an inflammation-related protein in the highest quartile for gestational age and collection day had an erythropoietin concentration in the highest or lowest quartile. Results: The proportion of children with inflammation-associated protein concentrations in the top quartile tended to increase monotonically with increasing quartile of EPO concentrations on 2 of the 3. days assessed. To a large extent, on each of the 3. days assessed, the odds ratios for an erythropoietin concentration in the top quartile were significantly elevated among those with an inflammation-related protein concentration in the top quartile. Conclusions: Our findings suggest that in very preterm newborns, circulating levels of endogenous erythropoietin vary significantly with circulating levels of inflammation-related proteins. Elevation of endogenous erythropoietin might not be an epiphenomenon, but instead might contribute to subsequent events, by either promoting or reducing inflammation, or by promoting an anti-injury or repair capability.

Idioma originalEnglish
Páginas (desde-hasta)22-28
Número de páginas7
PublicaciónCytokine
Volumen69
N.º1
DOI
EstadoPublished - sept 2014
Publicado de forma externaSí

Huella

Profundice en los temas de investigación de 'Endogenous erythropoietin varies significantly with inflammation-related proteins in extremely premature newborns'. En conjunto forman una huella única.

Citar esto